Bio-manufacturing of Saccharomyces Cerevisiae: Lallemnad Inc.

Bio-manufacturing of Saccharomyces Cerevisiae: Lallemnad Inc.

 

Overview and Detail

A French immigrant, A. Schurer, founded Lallemand. In 1915, Fred built the first company plant, which he called Lallemand. But 30 years later, the company was acquired by Roland Chagnon. From the company has grown into multinational. It has several subsidiaries across Europe and American, and it is headquarters, Rexdale, Ontario, Canada. Url: https://www.lallemand.com/. The company has 6000 employees across its 32 locations.

Products and services

            The company specializes in the development of the production and marketing of yeast, bacteria, and other derivatives for the food, fermented beverages, health, and other agriculture industries. Saccharomyces cerevisiae is one of the bioengineered product as yeast strain. The sales Saccharomyces cerevisiae to other companies as well as they use for brew production across its production plants. The company is focusing on several fields (Nilova & Malyutenkova, 2017). Thus, its customers include companies from baking, animal nutrition, pharm, plant care, cosmetics, and brewing (ethanol and spirits).

Therefore, the company focuses on several groups. According to Gombau et al. (2019), the acquisition of several companies by Lallemand has helped to go beyond its yeast-related production for the industrial, home, and microbrewer. Its global business is serving several segments with its products and services. The company does not rely on contractions. Yes, Lallemand is vertically integrated. The company controls the most process in its productions, ranging from research, development, and manufacturing and marketing of yeast, bacteria, and other products and services.

Financial

            The company is focused on its customers and partners to optimizes and integrated into current production to emerging technology and access new markets. The company is worth $2 billion. In the last years, over $100 million revenues across its subsidiaries.  Its competitors include; Hansen Pty Ltd, Lesaffre. Ab Mauri, and Danisco Corporation. Lallemand is not listed in any stock market. But it is one of the growing companies, especially in brewing and animal nutrition innovations and technologies.

Product market

            As mentioned, the Lallemand is a global leader in yeast and bacteria production. Therefore, its product-market relies on food, brewing, and agricultural sectors.  With it advances microbial protein technology, the company has acquired extensive market segmentation in the food industry, especially in Europe. Also, the company has purchased several companies to extend its market size. The primary customers are brewing and food companies across the globe. The is the bio-manufacturing company that sells yeast and Bactria to 11 industries (Rosend et al., 2019).

Product

According to Dey (2018), Lesaffre and ABF have been sharing the European market at 30%, followed by Lallemand, but today Lallmand seems to be fast-growing and may achieve its market share of 10%.  The company market shares across the globe are at 30%.  With Europe being the largest market, it is essential to put more strategies to break the duopoly of the two companies. But with the reason that Lallmand is dominant in Canada, the USA, and some parts of South America, its clear indication that it has an advantage over other companies when it comes to loyal customers and market penetration in other regions such as Africa.

Analysis of future plants.

            According to Romano et al. (2019), probiotics markets shear, sizes, and the global trend is forecasted at $74.69 billion by 2025. Therefore, Lallemand will exhibit a growth of 7.5% in a few years. Lallemand has put more plants in making partnerships with food companies in Europe and other evolving markets across the world.